(Q86056754)

English

The effect of combined treatment of bevacizumab and triamcinolone for diabetic macular edema refractory to previous intravitreal mono-injections

scientific article published on 26 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

The effect of combined treatment of bevacizumab and triamcinolone for diabetic macular edema refractory to previous intravitreal mono-injections (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

diabetic macular edema

1 reference

based on heuristic

inferred from title

author name string

Ümit Yolcu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Güngör Sobaci

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

26 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

International Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

73-79

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25425105%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

https://scigraph.springernature.com/pub.10.1007/s10792-014-0019-5

0 references

Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy in diabetic macular oedema and retinal vein occlusion--past and present

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis and review on the effect of bevacizumab in diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendation for the implementation of intravitreal injections--statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal ranibizumab (lucentis) for the treatment of diabetic macular edema: a systematic review and meta-analysis of randomized clinical control trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of anteroposterior keratocyte density in the normal rabbit cornea

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25425105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86056754&oldid=1527475019"